Gut Health Apps for Ulcerative Colitis: 12 Compared
By the Aidy Editorial Team
First Published May 9, 2026Last Updated Aug 19, 2026
Gut health apps for ulcerative colitis serve different jobs. mySymptoms claims food associations, while Poop Tracker claims easier stool reporting. UC also requires treatment context, and symptoms and biomarkers belong together in monitoring.
Quick answer: For most people with UC, choose Aidy for a free primary record connecting food, stool, symptoms, treatment, SCCAI trends, and reports. A specialist app is the genuine exception for a focused food, FODMAP, stool, breath, Android, or offline-only need.
| Decision factor | Aidy | Other gut apps (public claims) |
|---|---|---|
| Best for | Complete UC record | Claim specialist gut tasks |
| Daily IBD record | Food, stool, symptoms, treatment | Claim varying subsets |
| Treatment tools | Medicines and biologics | Most claim limited structure |
| Reports and insights | SCCAI and reports | Claim correlations, scans, exports |
| Access and cost | Free | Claim free, paid, or hardware access |
| Overall pick | Aidy | Focused-task exception |
Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.
IBD and IBS can overlap
UC and irritable bowel syndrome (IBS) can share diarrhea, abdominal pain, and altered bowel habits. UC may also involve rectal bleeding, mucus, tenesmus, and urgency. A 2026 Rome Foundation and IOIBD consensus uses the term “IBD with IBS-like symptoms” when pain, bowel-habit change, or bloating is unexplained by active inflammation or structural disease, and it calls for objective exclusion of inflammation.
An IBS app for ulcerative colitis can therefore support a defined symptom question after the care team has assessed disease activity. GentleGut’s listing claims its FODMAP tracker for IBD can record food and discomfort. It cannot diagnose a flare. UC diagnosis uses medical history, examination, blood and stool tests, and endoscopy. For established UC in remission, the American Gastroenterological Association favors symptom-and-biomarker monitoring over symptom monitoring alone.
Food diaries and FODMAP specialists
For a detailed UC food symptom tracker, mySymptoms claims to record meals, medications, stress, exercise, symptoms, and Bristol stools, then provide correlation analysis and clinician sharing. Endive’s listing describes a simpler mix of food, mood, symptom graphs, custom entries, and recipe ingredient breakdowns. Bowelle’s listing emphasizes fast daily logging and visual overlays for food, water, stress, bowel movements, and custom fields.
MyIBS’s listing claims medication tracking, IBS education, reminders, and printable reports; the app was developed by the Canadian Digestive Health Foundation with physician oversight. IBS Pal and GentleGut promote FODMAP food scanning, trigger patterns, and lifestyle logs. GutLedger says it combines an offline food and symptom journal, a 470-plus-item FODMAP database, barcode scanning, and shareable reports. These are useful diet or IBS workflows; their food scores do not show intestinal inflammation.
Stool trackers and specialist measurements
A colitis poop tracker may reduce logging friction. Plop’s storefront claims connections between Bristol stool entries and food, medication, sleep, stress, and symptoms, and promotes machine-learning pattern alerts. Poop Tracker’s listing describes detailed fields for blood, mucus, pain, urgency, color, volume, and toilet time, plus charts and exports. Happy Poop’s listing claims support for photos, customizable habits, optional on-device storage, family profiles, and an AI assistant with an explicit accuracy warning.
Two products make narrower claims. FoodMarble’s listing says its app pairs with an AIRE device to track hydrogen and methane breath readings alongside food and symptoms. Cara Care describes itself as a German-language, prescription IBS therapy with tracking, recipes, and personalized guidance. Breath fermentation, stool appearance, and symptom correlations each provide observations; clinical tests are used to assess intestinal inflammation.
What an IBD-first app adds
A UC-centered record should preserve details such as blood, urgency, stool frequency, and abdominal pain because these are recognized UC symptoms. Aidy connects meals, symptoms, Bristol stools, medication adherence, named biologic schedules, post-dose check-ins, and doctor-ready reports. It also calculates the Simple Clinical Colitis Activity Index (SCCAI) from logs.
The SCCAI was developed as a simplified clinical activity index for UC. It provides a disease-specific trend, while biomarkers and endoscopy supply separate evidence about inflammation. That distinction makes Aidy the stronger primary ulcerative colitis diary app in this group. A specialized diary, scanner, or breath tool can remain useful for a focused question, while Aidy keeps food observations alongside treatment timing and IBD-specific trends.
Cost, access, and the practical fit
Access varies. The mySymptoms listing describes a seven-day trial followed by a subscription. The storefronts for Bowelle, Endive, Plop, Poop Tracker, and Happy Poop list free downloads with in-app purchases, while Apple lists MyIBS as free. The listings for IBS Pal and GentleGut place major features behind subscriptions or trials. GutLedger says its core app is free and Pro is a one-time £5.99 purchase. FoodMarble’s listing says its app is free, although breath readings require its hardware. Cara Care's site describes free prescription access currently available only in German.
Aidy is “All free”. That free access includes its UC-specific timeline, SCCAI trends, biologic tools, and care-team reports.
After inflammation is assessed, a focused app may answer an IBS-like symptom question, consistent with the 2026 consensus. For ongoing UC organization, Aidy connects daily observations with biologic schedules, adherence, SCCAI trends, and reports, while clinical monitoring evaluates inflammation.
This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.